Elevance Health's Q1 2026 revenue rose to $50.2B, but net income fell to $1.8B due to Medicare risk-adjustment accruals and transformation costs, while operating cash flow was $4.3B and $1.1B was repurchased.Abstract: Elevance Health reports higher first-quarter revenue driven by $50.2 billion in 2026, but net income declined to $1.8 billion due to a Medicare Advantage risk-adjustment accrual and transformation program costs. Despite charges, operating cash flow reached $4.3 billion and $1.1 billion of shares were repurchased, indicating solid cash generation and conservative capital allocation despite earnings pressure.

NodeGuardian

2026-05-07 11:10:21

Abstract generation in progress

Elevance Health Inc. reported higher Q1 2026 revenue of $50.2 billion, up from $48.9 billion, but experienced a significant drop in net income to $1.8 billion from $2.2 billion year-over-year. This decline was primarily due to a $935 million accrual related to Medicare Advantage risk-adjustment data and $129 million in costs for its 2026–2027 Operating Model Transformation Program. Despite these charges, the company generated $4.3 billion in operating cash flow and repurchased $1.1 billion in shares.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

Reward
like
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
GateSquareMayTradingShare
607.5K Popularity
#
BTCPullback
106.33M Popularity
#
CLARITYActStalled
3.29M Popularity
#
CryptoStocksRally
1.52M Popularity
#
DailyPolymarketHotspot
840.55K Popularity

Sitemap

Elevance Health (NYSE: ELV) Q1 2026 earnings fall on $935M Medicare accrual

Trending Topics

GateSquareMayTradingShare

BTCPullback

CLARITYActStalled

CryptoStocksRally

DailyPolymarketHotspot

Pin